TABLE 3.
Molecule | Ligand | EC50 |
---|---|---|
pm | ||
Aflibercept | Human VEGF-A165 | 86 (10.3) |
VEGF dual dAb | Human VEGF-A165 | 32 (2.7) |
Aflibercept | Human VEGF-A121 | 317 (83.0) |
VEGF dual dAb | Human VEGF-A121 | 127 (22.1) |
Aflibercept | Murine VEGF-A164 | 95 (20.2) |
VEGF dual dAb | Murine VEGF-A164 | 36 (4.7) |